BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3533124)

  • 1. Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprusside.
    Becker RH; Struthers AD; Brown MJ
    Br J Clin Pharmacol; 1986 Oct; 22(4):409-13. PubMed ID: 3533124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of captopril on the renin-angiotensin system and the sympathetic nervous system during sodium nitroprusside-induced hypotension in the halothane-anesthetized rabbit.
    Stead SW; Bloor BC
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):465-71. PubMed ID: 1691371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril modifies the hemodynamic and neuroendocrine responses to sodium nitroprusside in hypertensive patients.
    Clementi WA; Durst NL; McNay JL; Keeton TK
    Hypertension; 1986 Mar; 8(3):229-37. PubMed ID: 3512428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenaline.
    Kondowe GB; Copeland S; Passmore AP; Leahey WJ; Johnston GD
    Eur J Clin Pharmacol; 1987; 32(3):229-35. PubMed ID: 3297732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal response to captopril pre-treatment during sodium nitroprusside-induced hypotension in man.
    Jacob L; Bonnet F; Sabathier C; Chiron B; Lhoste F; Viars P
    Eur J Anaesthesiol; 1987 Mar; 4(2):101-12. PubMed ID: 3297678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accentuated hypotensive effect of sodium nitroprusside in man after captopril.
    Jennings GL; Gelman JS; Stockigt JR; Korner PI
    Clin Sci (Lond); 1981 Nov; 61(5):521-6. PubMed ID: 7026130
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of captopril on hemodynamic and hormonal effects of nitroprusside.
    Fahmy NR; Gavras HP
    J Cardiovasc Pharmacol; 1985; 7(5):869-74. PubMed ID: 2413294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dietary sodium on renin angiotensin system involvement in sodium nitroprusside hypotension in conscious rats.
    Vollmer RR; Bush EN; Abukhres MM
    J Pharmacol Exp Ther; 1981 Mar; 216(3):580-5. PubMed ID: 7009830
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic and humoral effects of lower body negative pressure in normal, sodium-replete man during angiotensin-converting enzyme inhibition with captopril.
    Rasmussen S; Hesse B; Bonde-Petersen F; Damkjaer Nielsen M; Christensen NJ; Giese J; Warberg J
    Scand J Clin Lab Invest; 1986 Feb; 46(1):81-8. PubMed ID: 3006218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans.
    Ottesen MM; Worck R; Ibsen H
    Blood Press; 1997 Jan; 6(1):29-34. PubMed ID: 9116923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension.
    Morganti A; Sala C; Turolo L; Palermo A; Zanchetti A
    J Hypertens; 1985 Feb; 3(1):55-61. PubMed ID: 2987342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nifedipine and captopril on renal function in patients with essential hypertension: comparison with sodium nitroprusside.
    Hara A; Matsunaga M; Ogawa K; Pak CH; Kawai C; Nakamura T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S164-6. PubMed ID: 2455123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the renin-angiotensin system by sodium nitroprusside in essential hypertension.
    Shepherd AM; Pinkley W; Lin MS; McNay JL; Keeton TK
    J Cardiovasc Pharmacol; 1984; 6(1):201-5. PubMed ID: 6199605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of beta-adrenergic receptor mediated renin release to the maintenance of blood pressure during nitroprusside infusion in conscious rats.
    Bush EN; Vollmer RR
    Clin Exp Hypertens A; 1984; 6(12):2161-72. PubMed ID: 6099784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esmolol for potentiation of nitroprusside-induced hypotension: impact on the cardiovascular, adrenergic, and renin-angiotensin systems in man.
    Edmondson R; Del Valle O; Shah N; Wong G; Dwyer D; Matarazzo D; Thorne A; Coffey C; Bedford R
    Anesth Analg; 1989 Aug; 69(2):202-6. PubMed ID: 2569849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril reduces the dose requirement for sodium nitroprusside induced hypotension.
    Woodside J; Garner L; Bedford RF; Sussman MD; Miller ED; Longnecker DE; Epstein RM
    Anesthesiology; 1984 May; 60(5):413-7. PubMed ID: 6324616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma vasopressin, renin and catecholamines during nitroprusside-induced hypotension in the newborn lamb.
    Zubrow AB; Daniel SS; Stark RI; Husain MK; James LS
    J Perinat Med; 1989; 17(4):271-7. PubMed ID: 2696775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral presynaptic facilitatory effect of angiotensin II on noradrenaline release in anesthetized rabbits.
    Szabo B; Hedler L; Schurr C; Starke K
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):968-75. PubMed ID: 1694920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of felodipine on blood pressure and humoral factors in sodium-replete humans at rest and during exercise.
    Lijnen P; Hespel P; Fagard R; Staessen J; M'Buyamba-Kabangu JR; Moerman E; Amery A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S122-5. PubMed ID: 2455111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.